286 related articles for article (PubMed ID: 25971914)
1. Functional Analysis of microRNA in Multiple Myeloma.
Di Martino MT; Amodio N; Tassone P; Tagliaferri P
Methods Mol Biol; 2016; 1375():181-94. PubMed ID: 25971914
[TBL] [Abstract][Full Text] [Related]
2. A systems biology approach for miRNA-mRNA expression patterns analysis in non-small cell lung cancer.
Najafi A; Tavallaei M; Hosseini SM
Cancer Biomark; 2016; 16(1):31-45. PubMed ID: 26484609
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA‑506 participates in pancreatic cancer pathogenesis by targeting PIM3.
Du J; Zheng X; Cai S; Zhu Z; Tan J; Hu B; Huang Z; Jiao H
Mol Med Rep; 2015 Oct; 12(4):5121-6. PubMed ID: 26238203
[TBL] [Abstract][Full Text] [Related]
4. Potential roles of microRNAs and their target genes in human multiple myeloma.
Yang Y; Lin J; Ma Z; Li J; Li D; Wang B; Fei Q
Eur J Haematol; 2017 Aug; 99(2):178-185. PubMed ID: 28467652
[TBL] [Abstract][Full Text] [Related]
5. Dissecting the biological relationship between TCGA miRNA and mRNA sequencing data using MMiRNA-Viewer.
Bai Y; Ding L; Baker S; Bai JM; Rath E; Jiang F; Wu J; Jiang H; Stuart G
BMC Bioinformatics; 2016 Oct; 17(Suppl 13):336. PubMed ID: 27766936
[TBL] [Abstract][Full Text] [Related]
6. Human microRNA target identification by RRSM.
Hsieh WJ; Wang H
J Theor Biol; 2011 Oct; 286(1):79-84. PubMed ID: 21736879
[TBL] [Abstract][Full Text] [Related]
7. Identification of miR-145 targets through an integrated omics analysis.
Huang TC; Renuse S; Pinto S; Kumar P; Yang Y; Chaerkady R; Godsey B; Mendell JT; Halushka MK; Civin CI; Marchionni L; Pandey A
Mol Biosyst; 2015 Jan; 11(1):197-207. PubMed ID: 25354783
[TBL] [Abstract][Full Text] [Related]
8. miR-137 and miR-197 Induce Apoptosis and Suppress Tumorigenicity by Targeting MCL-1 in Multiple Myeloma.
Yang Y; Li F; Saha MN; Abdi J; Qiu L; Chang H
Clin Cancer Res; 2015 May; 21(10):2399-411. PubMed ID: 25724519
[TBL] [Abstract][Full Text] [Related]
9. miR-15a and miR-16 affect the angiogenesis of multiple myeloma by targeting VEGF.
Sun CY; She XM; Qin Y; Chu ZB; Chen L; Ai LS; Zhang L; Hu Y
Carcinogenesis; 2013 Feb; 34(2):426-35. PubMed ID: 23104180
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA expression profiling of human bone marrow mesenchymal stem cells during osteogenic differentiation reveals Osterix regulation by miR-31.
Baglìo SR; Devescovi V; Granchi D; Baldini N
Gene; 2013 Sep; 527(1):321-31. PubMed ID: 23827457
[TBL] [Abstract][Full Text] [Related]
11. Post-transcriptional Modifications Contribute to the Upregulation of Cyclin D2 in Multiple Myeloma.
Misiewicz-Krzeminska I; Sarasquete ME; Vicente-Dueñas C; Krzeminski P; Wiktorska K; Corchete LA; Quwaider D; Rojas EA; Corral R; Martín AA; Escalante F; Bárez A; García JL; Sánchez-García I; García-Sanz R; San Miguel JF; Gutiérrez NC
Clin Cancer Res; 2016 Jan; 22(1):207-17. PubMed ID: 26341922
[TBL] [Abstract][Full Text] [Related]
12. Integrative high-resolution microarray analysis of human myeloma cell lines reveals deregulated miRNA expression associated with allelic imbalances and gene expression profiles.
Lionetti M; Agnelli L; Mosca L; Fabris S; Andronache A; Todoerti K; Ronchetti D; Deliliers GL; Neri A
Genes Chromosomes Cancer; 2009 Jun; 48(6):521-31. PubMed ID: 19306352
[TBL] [Abstract][Full Text] [Related]
13. Cell-type-specific signatures of microRNAs on target mRNA expression.
Sood P; Krek A; Zavolan M; Macino G; Rajewsky N
Proc Natl Acad Sci U S A; 2006 Feb; 103(8):2746-51. PubMed ID: 16477010
[TBL] [Abstract][Full Text] [Related]
14. Dysregulation of microRNA-204 mediates migration and invasion of endometrial cancer by regulating FOXC1.
Chung TK; Lau TS; Cheung TH; Yim SF; Lo KW; Siu NS; Chan LK; Yu MY; Kwong J; Doran G; Barroilhet LM; Ng AS; Wong RR; Wang VW; Mok SC; Smith DI; Berkowitz RS; Wong YF
Int J Cancer; 2012 Mar; 130(5):1036-45. PubMed ID: 21400511
[TBL] [Abstract][Full Text] [Related]
15. Functional role of LASP1 in cell viability and its regulation by microRNAs in bladder cancer.
Chiyomaru T; Enokida H; Kawakami K; Tatarano S; Uchida Y; Kawahara K; Nishiyama K; Seki N; Nakagawa M
Urol Oncol; 2012; 30(4):434-43. PubMed ID: 20843712
[TBL] [Abstract][Full Text] [Related]
16. Genome-wide pharmacologic unmasking identifies tumor suppressive microRNAs in multiple myeloma.
Bi C; Chung TH; Huang G; Zhou J; Yan J; Ahmann GJ; Fonseca R; Chng WJ
Oncotarget; 2015 Sep; 6(28):26508-18. PubMed ID: 26164366
[TBL] [Abstract][Full Text] [Related]
17. MicroRNAs in the pathobiology of multiple myeloma.
Lionetti M; Agnelli L; Lombardi L; Tassone P; Neri A
Curr Cancer Drug Targets; 2012 Sep; 12(7):823-37. PubMed ID: 22671930
[TBL] [Abstract][Full Text] [Related]
18. Integrated analysis of microRNAs, transcription factors and target genes expression discloses a specific molecular architecture of hyperdiploid multiple myeloma.
Di Martino MT; Guzzi PH; Caracciolo D; Agnelli L; Neri A; Walker BA; Morgan GJ; Cannataro M; Tassone P; Tagliaferri P
Oncotarget; 2015 Aug; 6(22):19132-47. PubMed ID: 26056083
[TBL] [Abstract][Full Text] [Related]
19. A p53-dependent tumor suppressor network is induced by selective miR-125a-5p inhibition in multiple myeloma cells.
Leotta M; Biamonte L; Raimondi L; Ronchetti D; Di Martino MT; Botta C; Leone E; Pitari MR; Neri A; Giordano A; Tagliaferri P; Tassone P; Amodio N
J Cell Physiol; 2014 Dec; 229(12):2106-16. PubMed ID: 24819167
[TBL] [Abstract][Full Text] [Related]
20. MiRNome expression is deregulated in the peripheral lymphoid compartment of multiple myeloma.
Campo S; Allegra A; D'Ascola A; Alonci A; Scuruchi M; Russo S; Avenoso A; Gerace D; Campo GM; Musolino C
Br J Haematol; 2014 Jun; 165(6):801-13. PubMed ID: 24620752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
